Tetanus (Clostridium tetani)

Overview


Plain-Language Overview

Tetanus is a serious infection caused by a bacterium called Clostridium tetani that affects the nervous system. It usually enters the body through a deep cut or wound and produces a toxin that causes muscles to become very stiff and spasm. The infection mainly affects the muscles used for breathing and swallowing, which can be life-threatening. Early symptoms include jaw stiffness, often called lockjaw, and difficulty opening the mouth. As the disease progresses, muscle spasms can spread to the neck, chest, and back. The nervous system is disrupted by the toxin, leading to painful and uncontrollable muscle contractions. Without treatment, tetanus can cause severe complications and even death.

Clinical Definition

Tetanus is a potentially fatal neurological disorder caused by the neurotoxin tetanospasmin produced by the anaerobic, spore-forming bacterium Clostridium tetani. The toxin blocks inhibitory neurotransmitter release (glycine and GABA) at the spinal cord and brainstem, leading to disinhibition of motor neurons and characteristic muscle rigidity and spasms. The disease typically follows contamination of wounds with C. tetani spores, which germinate in anaerobic conditions. Clinically, it presents with trismus (lockjaw), risus sardonicus, and generalized muscle spasms that can cause respiratory failure. The incubation period ranges from 3 to 21 days, with shorter periods correlating with more severe disease. Diagnosis is primarily clinical, as the organism is rarely isolated from wounds. Tetanus remains a medical emergency due to its high morbidity and mortality without prompt management.

Inciting Event

  • Contaminated wound inoculation with Clostridium tetani spores is the typical trigger.

  • Puncture injuries, burns, surgical wounds, or animal bites can introduce spores.

  • Injection drug use with non-sterile needles can serve as an inciting event.

Latency Period

  • Symptoms typically develop 3 to 21 days after inoculation, with an average of 7 to 10 days.

  • Shorter incubation periods (<3 days) correlate with more severe disease.

  • Longer latency periods up to several weeks can occur depending on wound site and bacterial load.

Diagnostic Delay

  • Early symptoms such as jaw stiffness and neck pain are often misattributed to dental or musculoskeletal causes.

  • Lack of recent wound history or unrecognized minor wounds delays suspicion of tetanus.

  • Low clinical awareness in vaccinated populations can lead to missed diagnosis.

  • Absence of specific laboratory tests necessitates diagnosis based on clinical presentation, which may be overlooked.

Clinical Presentation


Signs & Symptoms

  • Muscle stiffness and painful spasms starting near the wound site and progressing

  • Difficulty swallowing and neck stiffness

  • Autonomic dysfunction including sweating, fever, and labile hypertension

  • Respiratory distress from laryngeal spasm or chest wall rigidity

  • Irritability and restlessness due to central nervous system involvement

History of Present Illness

  • Initial symptoms include trismus (lockjaw) and neck stiffness progressing to generalized muscle rigidity.

  • Painful muscle spasms triggered by minimal stimuli such as noise or touch develop within days.

  • Progression to opisthotonos (arched back) and respiratory muscle involvement can cause respiratory failure.

  • Autonomic dysfunction with labile blood pressure and tachycardia may occur in severe cases.

Past Medical History

  • Incomplete or absent tetanus vaccination history is a key risk factor.

  • History of recent trauma, surgery, or injection drug use increases suspicion.

  • Chronic illnesses causing immunosuppression may worsen disease severity.

Family History

  • There are no known heritable patterns or familial syndromes associated with tetanus.

  • Family history is generally not relevant to disease risk or presentation.

Physical Exam Findings

  • Trismus (lockjaw) with inability to open the mouth fully

  • Risus sardonicus, a sustained spasm of facial muscles causing a grimace

  • Opisthotonos, severe hyperextension and spasticity of the neck and back

  • Generalized muscle rigidity and spasms triggered by minimal stimuli

  • Hyperreflexia due to disinhibition of motor neurons

Diagnostic Workup


Diagnostic Criteria

Diagnosis of tetanus is clinical and based on the presence of muscle rigidity, especially trismus, and painful muscle spasms following a history of a contaminated wound or injury. There are no definitive laboratory tests; isolation of Clostridium tetani from wounds is uncommon and not required for diagnosis. The diagnosis is supported by the absence of other causes of muscle rigidity and spasms. Key features include risus sardonicus, opisthotonus, and autonomic dysfunction in the appropriate clinical context.

Pathophysiology


Key Mechanisms

  • Tetanospasmin neurotoxin produced by Clostridium tetani blocks release of inhibitory neurotransmitters GABA and glycine at the spinal cord.

  • Loss of inhibitory input causes disinhibition of motor neurons, leading to muscle rigidity and spasms.

  • Retrograde axonal transport of toxin from wound site to central nervous system is essential for pathogenesis.

  • Sustained muscle contraction results from continuous motor neuron firing due to impaired inhibitory signaling.

InvolvementDetails
Organs

Central nervous system is the primary organ system affected, with toxin-mediated disruption of inhibitory interneurons causing generalized muscle spasms.

Respiratory system involvement can lead to respiratory failure from diaphragmatic and accessory muscle spasms.

Tissues

Neural tissue in the spinal cord and brainstem is affected by tetanospasmin, disrupting inhibitory synaptic transmission.

Muscle tissue exhibits sustained contraction and rigidity due to loss of inhibitory control.

Cells

Motor neurons are the primary target of tetanospasmin toxin, leading to inhibition of inhibitory neurotransmitter release and resultant muscle rigidity.

Plasma cells produce antibodies after vaccination or immune globulin administration to neutralize tetanospasmin.

Chemical Mediators

Tetanospasmin is the neurotoxin produced by Clostridium tetani that blocks release of inhibitory neurotransmitters causing spastic paralysis.

GABA and glycine are inhibitory neurotransmitters whose release is blocked by tetanospasmin, leading to unopposed muscle contraction.

Acetylcholine release at the neuromuscular junction remains intact, causing continuous muscle contraction.

Treatments


Pharmacological Treatments

  • Tetanus immune globulin (TIG)

    • Mechanism:
      • Neutralizes unbound tetanospasmin toxin to prevent further neuronal uptake.

    • Side effects:
      • Injection site pain

      • Allergic reactions

      • Fever

    • Clinical role:
      • First-line

  • Metronidazole

    • Mechanism:
      • Inhibits anaerobic bacterial DNA synthesis to eradicate Clostridium tetani.

    • Side effects:
      • Gastrointestinal upset

      • Metallic taste

      • Peripheral neuropathy

    • Clinical role:
      • First-line

  • Benzodiazepines

    • Mechanism:
      • Enhance GABA-A receptor activity to reduce muscle spasms and rigidity.

    • Side effects:
      • Sedation

      • Respiratory depression

      • Dependence

    • Clinical role:
      • Adjunctive

  • Magnesium sulfate

    • Mechanism:
      • Acts as a calcium antagonist and neuromuscular blocker to control severe muscle spasms.

    • Side effects:
      • Hypotension

      • Respiratory depression

      • Flushing

    • Clinical role:
      • Adjunctive

Non-pharmacological Treatments

  • Supportive care with airway management and mechanical ventilation if respiratory muscles are involved.

  • Wound debridement to remove necrotic tissue and reduce bacterial load.

  • Isolation in a quiet, dark environment to minimize external stimuli triggering spasms.

  • Nutritional support and hydration to maintain metabolic demands during illness.

Prevention


Pharmacological Prevention

  • Tetanus toxoid vaccine administered in childhood and booster doses every 10 years

  • Tetanus immune globulin (TIG) for passive immunization after high-risk wounds in unimmunized individuals

  • Antibiotic prophylaxis with metronidazole or penicillin for contaminated wounds

Non-pharmacological Prevention

  • Proper wound care including thorough cleaning and debridement

  • Avoidance of contaminated soil or objects in open wounds

  • Public health measures to improve vaccination coverage

  • Education on timely medical evaluation of wounds

Outcome & Complications


Complications

  • Respiratory failure due to diaphragmatic and laryngeal muscle spasms

  • Aspiration pneumonia from impaired swallowing and airway protection

  • Autonomic instability causing cardiac arrhythmias and blood pressure fluctuations

  • Fractures from severe muscle spasms

  • Death if untreated or in severe cases

Short-term Sequelae Long-term Sequelae
  • Prolonged muscle rigidity and spasms requiring intensive care support

  • Secondary infections including pneumonia and wound infections

  • Need for mechanical ventilation due to respiratory muscle involvement

  • Residual muscle weakness or contractures from prolonged spasms

  • Psychological sequelae such as post-ICU syndrome or PTSD

  • Neurological deficits are uncommon if treated promptly

Differential Diagnoses


Tetanus (Clostridium tetani) versus Strychnine poisoning

Tetanus (Clostridium tetani)

Strychnine poisoning

History of wound contamination with soil or rusty metal object

Recent ingestion or exposure to rodenticide or pesticide containing strychnine

Gradual onset of symptoms over days after inoculation

Rapid onset of symptoms within minutes to hours after exposure

Requires administration of human tetanus immune globulin and antibiotics

Symptoms improve with administration of activated charcoal and supportive care

Tetanus (Clostridium tetani) versus Hypocalcemic tetany

Tetanus (Clostridium tetani)

Hypocalcemic tetany

Normal serum calcium and phosphate levels

Low serum calcium levels with elevated phosphate

Generalized muscle rigidity and risus sardonicus

Carpopedal spasms and positive Chvostek and Trousseau signs

Improvement with tetanus immune globulin and wound debridement

Improvement with intravenous calcium administration

Tetanus (Clostridium tetani) versus Dystonic reaction

Tetanus (Clostridium tetani)

Dystonic reaction

No recent neuroleptic or dopamine antagonist exposure

Recent use of dopamine antagonist medications such as antipsychotics or metoclopramide

Generalized muscle rigidity with trismus and opisthotonus

Sustained involuntary muscle contractions localized to face, neck, or limbs

Requires tetanus immune globulin and supportive care

Rapid improvement with anticholinergic agents like benztropine or diphenhydramine

Tetanus (Clostridium tetani) versus Rabies

Tetanus (Clostridium tetani)

Rabies

History of wound contaminated with soil or rusty metal object

History of animal bite or exposure to bats

Muscle rigidity and spasms without encephalitis

Progressive encephalitis with hydrophobia and aerophobia

Isolation of Clostridium tetani or detection of tetanospasmin toxin

Detection of rabies virus RNA by PCR or Negri bodies on brain biopsy

Tetanus (Clostridium tetani) versus Neonatal tetanus

Tetanus (Clostridium tetani)

Neonatal tetanus

Onset typically in older children or adults after wound contamination

Onset within first 2 weeks of life in neonates

Wound contaminated with soil or rusty metal object

Unsterile delivery or umbilical stump contamination

Generalized rigidity and spasms with trismus and risus sardonicus in older patients

Generalized rigidity and spasms with poor feeding and weak cry in neonates

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.